Gregory Lawrence Verdine

This inventor holds 85 USPTO granted patents and 45 published patent applications, plus 6 CIPO patents and 18 EPO patents, primarily in Peptide Therapeutics (CPC class A61K38-00). Top assignees: Harvard College, Wave Life Sciences Ltd., Dana-Farber-Cancer Institute Inc.. Active years: 1998-2026.

USPTO Granted Patents = 85 (Patent Applications = 45)

% Patents Active = 76.5

CIPO Patents = 6 (Patent Applications = 11)

EPO Patents = 18 (Patent Applications = 41)

Average Co-Inventor Count = 3.3

ph-index = 27

Forward Citations = 2,045(Granted Patents)

Forward Citations (Not Self Cited) = 1,589(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Somerville, MA (US) (1998)
Cambridge, MA (US) (2002 - 2006)
Lexington, MA (US) (2000 - 2016)
Bedford, MA (US) (2018)
Newton, MA (US) (2007 - 2019)
Boston, MA (US) (2015 - 2024)

Company Filing History:

Wave Life Sciences Ltd.

patents

8 out of 1,265

Dana-Farber-Cancer Institute Inc.

patents

4. 7 out of 40

Revolution Medicines, Inc.

Ginkgo Bioworks, Inc.

patents

8. 2 out of 2

Fog Pharmaceuticals, Inc.

patents

9. 2 out of 2

Lifemine Therapeutics, Inc.

patents

10. 1 out of 44

Aileron Therapeutics, Inc.

Parabilis Medicines, Inc.

16. 4 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Peptides

Therapeutic Targets

Beta-Catenin

Chiral Design

Cooperative Binding

Protein-Protein Interfaces

Insulin Receptor Modulators

Nucleic Acid Prodrugs

Stabilized Compounds

Ras Inhibitory Peptides

Oligonucleotides

Functionalized Nucleic Acids

85 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637672 - Oligonucleotide compositions and methods thereof (2026-05-26),

2. 12398178 - Collections of peptides, peptide agents, and methods of use thereof (2025-08-26),

3. 12258423 - Stapled and stitched polypeptides and uses thereof (2025-03-25),

4. 12243623 - Human therapeutic targets and modulators thereof (2025-03-04),

5. 12180472 - Chiral design (2024-12-31),

6. 11987590 - Compounds that participate in cooperative binding and uses thereof (2024-05-21),

7. 11834482 - Agents modulating beta-catenin functions and methods thereof (2023-12-05),

8. 11749375 - Human therapeutic targets and modulators thereof (2023-09-05),

9. 11644460 - Identifying new therapeutic agents (2023-05-09),

10. 11643657 - Chiral control (2023-05-09),

11. 11479797 - Compositions and methods for the production of compounds (2022-10-25),

12. 11447810 - Compositions and methods for the production of compounds (2022-09-20),

13. 11377476 - Ras inhibitory peptides and uses thereof (2022-07-05),

14. 11332496 - Stapled and stitched polypeptides and uses thereof (2022-05-17),

15. 11198713 - Agents modulating beta-catenin functions and methods thereof (2021-12-14),

Title: The Innovative Journey of Gregory Lawrence Verdine

Introduction:

Gregory Lawrence Verdine is a distinguished inventor hailing from Boston, MA. His groundbreaking work in the field of biotechnology has revolutionized the way we approach drug discovery and development.

Latest Patents:

Gregory Lawrence Verdine holds several patents in the biotechnology sector, focusing on novel therapeutic approaches and innovative drug delivery systems. His patents showcase his commitment to pushing the boundaries of science and technology.

Career Highlights:

With a stellar academic background and extensive experience in the biotech industry, Gregory Lawrence Verdine has made significant contributions to the field. He has held key positions in renowned research institutions and biopharmaceutical companies, shaping the future of medicine.

Collaborations:

Throughout his career, Gregory Lawrence Verdine has collaborated with leading scientists, researchers, and industry experts to drive innovation and bring cutting-edge therapies to the market. His collaborative spirit has led to the development of groundbreaking technologies with far-reaching implications.

Conclusion:

In conclusion, Gregory Lawrence Verdine stands as a visionary inventor whose work continues to inspire and shape the landscape of biotechnology. His relentless pursuit of innovation and commitment to scientific excellence make him a true pioneer in the field.